-
February 14, 2013
Acorda Therapeutics Inc.'s (ACOR) fourth quarter earnings (including share-based compensation charges but excluding ...
-
February 11, 2013
Acorda Therapeutics, Inc. (ACOR) recently announced that data from preclinical studies evaluating glial growth ...
-
February 08, 2013
Coffee maker Green Mountain Coffee Roasters Inc. (GMCR) delivered robust first quarter 2013 adjusted earnings ...
-
February 06, 2013
We reaffirm our Neutral recommendation on Saks Inc (SKS) following appraisal of its third quarter fiscal 2013 ...
-
February 04, 2013
Global food products maker and distributor Sysco Corporation (SYY) reported better-than-expected second quarter ...
-
January 25, 2013
Acorda Therapeutics, Inc. (ACOR) recently announced that it has been awarded a research contract worth $2.67 million ...
-
January 22, 2013
Questcor Pharmaceuticals Inc. (QCOR) recently announced that it has completed the acquisition of BioVectera Inc. ...
-
January 17, 2013
The agricultural commodity market experienced quite the volatile 2012, thanks to the massive drought in the Midwest ...
-
January 15, 2013
Shares of technology bellwether Apple dipped, dragging the S&P 500 and Nasdaq lower on Monday after investors were ...
-
January 09, 2013
Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The company continues to ...
-
January 08, 2013
Acorda Therapeutics, Inc. (ACOR) recently disclosed unaudited sales of Ampyra (dalfampridine) extended release ...
-
January 03, 2013
This morning, the market has been relatively quiet. The Nasdaq remains relatively unchanged; the S&P 500 is ...
-
December 28, 2012
The market is currently down, with the Nasdaq decreasing 0.3%, the S&P 500 declining 0.5% and the Dow falling 0.5%. ...
-
December 27, 2012
Acorda Therapeutics, Inc. (ACOR) recently completed the acquisition of privately-held Neuronex, Inc. As per the ...
-
December 27, 2012
The market has been slipping so far today: the Nasdaq is trading down 0.7%; the S&P 500 has slipped 0.8%; and the ...
-
December 27, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq is down 0.7%; the S&P 500 is trading down ...
-
December 19, 2012
Celgene Corporation (CELG) recently collaborated with Sutro Biopharma for the development of novel antibody drug ...
-
December 17, 2012
ARIAD Pharmaceuticals (ARIA) recently announced positive data from the pivotal PACE study on ponatinib. ARIAD is ...
-
December 13, 2012
In a bid to expand its oncology pipeline, biopharmaceutical company Gilead Sciences Inc. (GILD) inked a definitive ...
-
December 05, 2012
The Nasdaq has declined 1%, the S&P 500 is trading down 0.1% and the Dow has risen 0.2% after the morning's trading. ...
